FUSITAB

Welcome to the Brand page for “FUSITAB”, which is offered here for Gene therapy and prophylaxis products, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems;instruments, apparatus surgical and medical apparatus and instruments, all for the administration of gene therapy treatment and for the administration of prophylaxis products, syringes, scalpels, catheters, and tubes for the administration of gene therapy products;scientific and medical research and product development; medical services; genetic engineering services; biotechnology services, research and development of new products in the field of biotechnology; scientific and medical research and development of new products in the field of gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “FUSITAB” is believed to be currently owned by “Oxford BioMedica plc”.